The slip
PARKINSON RECEIPTno. 9236
25 Oct 2026, 02:19 UTColigodendrocytes, braak
predictionINF2 in oligodendrocytes tracks Braak Lewy-body stage
registered3b02ee7dfa6144e6
discovery-0.55 p=0.125 n=9
replication-0.53 p=0.143 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.55, p 0.125)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT514223a9261e077659ac300a…
follows 2c36be63a3ba…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9236: INF2 in oligodendrocytes, braak
- power
- full sample -0.48 (p 0.044, n 18), 95% CI -0.77 to -0.02. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.53 (p 0.025, n 18). holds up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.53 (p 0.025, n 18). not the mix.
- skeptic
- leave-one-out range -0.57 to -0.41, sign flips 0; without severely affected donors -0.48 (p 0.044, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for INF2 in oligodendrocytes.
case closed: nothing better to follow up.